1. Hereditary Breast and Ovarian Cancer Screening Syndrome Profile in Women Diagnosed with Breast Cancer from Paraná State Southwest
    Juliana Batista de Moura et al, 2021, Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics CrossRef
  2. Salivary Gland Function, Antioxidant Defence and Oxidative Damage in the Saliva of Patients with Breast Cancer: Does the BRCA1 Mutation Disturb the Salivary Redox Profile?
    null Sawczuk et al, 2019, Cancers CrossRef
  3. Immunohistochemical Evaluation of BAP1 Expression in Breast Cancer with Known BRCA1 and BRCA2 Mutations and Comparison with Histopathological Features
    Begüm Çalım-Gürbüz et al, 2022, International Journal of Surgical Pathology CrossRef
  4. Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers
    Arsen Arakelyan et al, 2021, International Journal of Molecular Sciences CrossRef
  5. Therapeutic Options in BRCA1-Linked Breast Cancer and Systemic Approaches
    Amir Khan et al, 2022, Breast Cancer: From Bench to Personalized Medicine CrossRef
  6. Contribution of BRCA1 5382insC mutation to triplene-gative and luminal types of breast cancer in Ukraine
    Anastasiia Samusieva et al, 2022, Breast Cancer Research and Treatment CrossRef
  7. Sociodemographic, Clinical, and Variation Outcomes for Breast Cancer and Breast Cancer-Related Mutations in a Ten-Year Cohort From Neiva, Huila, Colombia
    Justo Olaya et al, 2022, Cureus CrossRef
  8. Breast cancer relapses considering molecular biological characteristics
    Ivan Ivanovich Smolanka et al, 2023, Journal of Medicine and Life CrossRef
  9. Implications of BRCA1 and BRCA2 Mutations in Mexico
    Carlos Arturo Gonzalez Nuñez et al, 2023, BRCA1 and BRCA2 Mutations - Diagnostic and Therapeutic Implications CrossRef
  10. KIF18A as a potential biomarker to distinguish different breast cancer subtypes based on receptor status
    Caglar Berkel, 2024, Genome Instability & Disease CrossRef
  11. Association between BRCA mutational status and survival in patients with breast cancer: a systematic review and meta-analysis
    Miao Liu et al, 2021, Breast Cancer Research and Treatment CrossRef
  12. Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline BRCA mutation?
    Sabah Alaklabi et al, 2023, Exploration of Targeted Anti-tumor Therapy CrossRef
  13. Risk factors of local relapses in patients with breast cancer depending on the properties of the primary tumor
  14. Opposing effects of BRCA1 mRNA expression on patient survival in breast and colorectal cancer and variations among African American, Asian, and younger patients
    Sofia Leaf et al, 2021, Oncotarget CrossRef